Kanghong Pharma cancels stock options from 2021 plan

Chengdu Kanghong Pharmaceutical Group Co., Ltd. (SZSE:002773) announced the completion of the cancellation of 198,750 stock options previously granted under its 2021 stock option incentive plan. The decision to cancel the options, initially approved at the company's April 25, 2025 board meeting, was due to the departure of 13 employees who were granted the stock options. The cancellation process has been verified by the Shenzhen branch of China Securities Depository and Clearing Corporation Limited. The company stated that the cancellation will not affect the normal implementation of the 2021 stock option incentive plan or have a significant impact on the company's financial condition and operating results. The board believes that the company's management team will continue to perform their duties diligently.